triple-negative breast cancer: clinical characteristics, prognostic features, and long-term outcome: a comparative study
نویسندگان
چکیده
background: because of the reported poor prognosis and absence of effective and specific therapeutic approaches, triple-negative breast cancer (tnbc) tumors have remained as an important area of investigations for clinicians and researchers. the aim of this study was to determine the clinical, pathological, histological, prognostic features, and outcome associated with this type of breast cancer in iran. we also tried to identify main determinants of long-term survival in women suffered from tnbc tumor type. methods: this is a historical cohort study of 546 consecutive female breast cancer patients with known status of hormonal receptors and diagnosed at the rasoul-e-akram university hospital of iran between january 2009 and june 2011. baseline data were collected from patient records and hospital charts. long-term outcome was determined from clinic records when available or by means of written correspondence with patients' physicians and telephone interviews directly with the patients or with family members. follow-up data were collected by our research personnel for a mean follow-up duration 5.7 years. results: a total of 86 of 546 final included participants with breast cancer were identified as having tnbc (15.8%).the patients with tnbc diagnosis were significantly younger than non-tnbc group and family history of breast cancer was more prevalent in former group. regarding histopathological feature, medullary feature was more prevalent in tnbc group, while other features were similarly revealed in both groups. with respect to tumor grading, tnbc group was graded higher than non-tnbc group that grade iii of tumor was reported in 51.1% of the tnbc patients, but in 15.9% of another group. also, the stage of tumor was significantly higher in the tnbc group. tumor size > 50 mm was observed in 18.6% of the tnbc and 14.8% of non-tnbc groups. metastasis to liver as well as concurrent metastasis to brain and pulmonary was more prevalent in tnbc compared with another group. the kaplan-meier curves based showed the survi al probability at 1-year, 3-year, and 5-year of follow-up in tnbc group was 92.7%, 86.2%, and 44.9%, respectively. this survival rates in non-tnbc group was 98.7%, 87/2%, and 72.5%, respectively. multivariable logistic regression analysis showed that tnbc diagnosis could strongly predict long-term mortality in breast cancer patients. besides, tumor size, number of involved lymph nodes and higher tumor grade were other determinants of cancer-related long-term mortality. conclusion: the present study on iranian tnbcs population shows that tnbcs account for about 15.8% of all invasive breast cancers, and they usually have a high histological stating and metastasis susceptibility.
منابع مشابه
Clinicopathological Features of Non-metastatic Triple Negative Breast Cancer
Background: Triple negative breast cancer (TNBC) is reported to be associated with a high risk of recurrence, poor overall survival (OS), and disease-free survival (DFS) rates. This study evaluated the clincopathological features and survival of non-metastatic TNBC women in the capital of Iran compared with other areas of the world. Methods: In a retrospective study, 119 women with TNBC based ...
متن کاملThe Clinical and Prognostic Significance of Triple-Negative Status Invasive Breast Cancer in a Sample of Iraqi Women
Introduction: Triple-negative breast cancer (TNBC) is a type of breast cancer that is negative for estrogen receptor, progesterone receptor, and HER2. This study aimed to evaluate the clinical outcomes and short-term prognosis of this type of cancer compared with other subtypes of breast cancer. Methods: A cross-sectional study was conducted on 108 women with invasive breast cancer. The patie...
متن کاملMolecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
BACKGROUND Triple-negative breast cancer is a subtype of breast cancer with aggressive tumor behavior and distinct disease etiology. Due to the lack of an effective targeted medicine, treatment options for triple-negative breast cancer are few and recurrence rates are high. Although various multi-gene prognostic markers have been proposed for the prediction of breast cancer outcome, most of the...
متن کاملTriple-negative breast cancer: clinical features and patterns of recurrence.
PURPOSE To compare the clinical features, natural history, and outcomes for women with "triple-negative" breast cancer with women with other types of breast cancer. EXPERIMENTAL DESIGN We studied a cohort of 1,601 patients with breast cancer, diagnosed between January 1987 and December 1997 at Women's College Hospital in Toronto. Triple-negative breast cancers were defined as those that were ...
متن کاملclinicopathological characteristics and outcome of triple negative breast cancers; a report from cancer institute of iran
introduction: triple negative breast cancers (tnbc) have a more aggressive course and are associated with poorer prognosis in comparison with other subtypes of breast cancer. one of the most common subtypes of tnbc is basal-like. the aim of this study was to investigate clinicopathological characteristics and clinical course of tnbc in iranian women and compare it with other studies. method: be...
متن کاملPrognostic markers in triple-negative breast cancer.
BACKGROUND Triple-negative breast cancer (estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) is a high risk breast cancer that lacks the benefit of specific therapy that targets these proteins. METHODS In this study, the authors examined a large and well characterized series of invasive breast carcinoma (n = 1944) with a long-term clinical follow-up (median, 56 mon...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
international journal of hematology-oncology and stem cell researchجلد ۶، شماره ۱، صفحات ۲۴-۲۹
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023